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The development of T cells from multipotent progenitors in the thymus occurs by cascades of interactions between signaling
molecules and transcription factors, resulting in the loss of alternative lineage potential and the acquisition of the T-cell functional
identity. These processes require Notch signaling and the activity of GATA3, TCF1, Bcl11b, and the E-proteins HEB and E2A. We
have shownthat HEB factors arerequired toinhibit thethymicNK cell fate andthat HEBAlt allows the passage ofT-cellprecursors
fromtheDNtoDPstagebutisinsuﬃcientforsuppressionoftheNKcelllineagechoice.HEBfactorsarealsorequiredtoenforcethe
death of cells that have not rearranged their TCR genes. The synergistic interactions between Notch1, HEBAlt, HEBCan, GATA3,
and TCF1 are presented in a gene network model, and the inﬂuence of thymic stromal architecture on lineage choice in the thymus
is discussed.
1.T-CellProgenitorsandLineagePlasticity
During hematopoiesis, pluripotent progenitors are sequen-
tially restricted in lineage potential and progressively com-
mitted to a single lineage choice. Lineage commitment is,
therefore, established in part by the inability to respond to
environmental cues, migrate to inductive environments,
and/or express key lineage regulatory factors that direct the
acquisition of alternative fate choices [1]. However, the thy-
mus, a site where T cells are generated, does not produce
stem cells, and the generation of T cells depends solely on the
intermittent input of progenitors from adult bone marrow
[2].Circulatingprogenitorssuchaslymphoid-primedmulti-
potent progenitors (LMPPs) or common-lymphoid progen-
itors (CLPs) enter the thymus at the corticomedullary junc-
tion (CMJ). During development, T-cell progenitors transi-
tion through two functionally distinct zones of the thymus:
immature cells migrate outward through the cortex, while
the more mature cells migrate inward toward medulla [1].
The developmental status of thymocytes can be identiﬁed
by their cell-surface marker expression. The most immature
progenitors lack the expression of CD4 and CD8 (double
negative, DN) and are further discriminated based on the
expression of CD44 and CD25 into four sequential stages:
DN1 (CD44+CD25−), DN2 (CD44+CD25+), DN3 (CD44−
CD25+), and DN4 (CD44−CD25−)[ 3].
The DN1 population is quite heterogeneous and has the
capacity to generate multiple lineages [4]. Since DN1a (c-
kit+CD24−) and DN1b (c-kit+CD24+) cells generate T cells
eﬃciently and exhibit a strong proliferative capacity, they are
consideredtobethecanonicalearlyT-cellprogenitors(ETP).
The remaining DN1 subsets, DN1c (c-kitintCD24−), DN1d
(c-kit−CD24+), and DN1e (c-kit−CD24−), are noncanonical
T-cell progenitors because they lack the proliferative poten-
tial and diﬀer substantially in their capacity to generate T
cells. The heterogeneity of the DN1 population reﬂects the
variety of non-T-cell lineages that are generated in the
thymus. While DN1c and DN1d cells give rise to B cells,
DN1a, DN1b, and to a small degree DN1e cells can produce
natural killer (NK) cells [4]. The DN1c, DN1d, and DN1e
subsets have also been shown to have the potential to gene-
rate dendritic cells (DCs) in the thymus [5, 6]. In addition,
ETPs can be further separated into two subsets based on the
expression of Flt3; the Flt3+ E T P sc a ng i v er i s et oBc e l l s ,
while Flt3− ETPs no longer possess B-cell potential [7].
Lastly, ETPs have the potential to generate myeloid cells in2 Clinical and Developmental Immunology
the thymus [8]. These studies indicate that B-cell potential
is lost before myeloid potential in T-cell precursors prior to
T-lineage commitment.
2.T-Cell Development: Gene
Speciﬁcation,Commitment,and
Developmental Checkpoints
Speciﬁcation into the T-cell lineage occurs during the tran-
sition from the DN1 to the DN2 stage, when lymphoid- and
T-lineage-speciﬁc genes are turned on [9]. Some of the most
important targets of T-lineage regulators include Rag genes,
interleukin 7 receptor α (IL7Rα), lck, Bcl11b, pTα,a n dCD3
genes. Based on the expression of lck and c-kit, DN2 cells
can be further separated into DN2a (lck−, c-kithiCD25+)a n d
DN2b (lck+, c-kitintCD25+) subpopulations, which display
diﬀerential lineage potential; while DN2a can give rise to
myeloid, NK, and DC cells, DN2b are T-lineage restricted
[10, 11]. However, the revised model of hematopoiesis, in
which the lymphoid-myeloid segregation occurs after the T-
Bs e g r e g a t i o n[ 8], has been recently challenged by a study
involving IL7R-reporter mice [12]. In this study, myeloid
cells did not arise from the cells that had a history of IL7R
expression as tracked by a fate-mapping reporter gene,
even in the DN1a and DN1b fractions [12]. These results
suggested that myeloid cells in the thymus may not share
a common intrathymic precursor with T-cells. Additional
studies are needed to resolve this issue.
T-lineage-restricted DN2b cells progress to the DN3
stage. At the DN3 stage, the TCRβ gene is rearranged and
expressed. Successfully produced TCRβ chains pair up with
invariant pTα chains, and with the CD3 components into
a pre-TCR complex. Signaling through the pre-TCR grants
survivalanddiﬀerentiationtotheDN4stage.Inaddition,the
cells turn oﬀ the expression of Rag genes in order to prevent
rearrangement of a second TCRβ allele, a process called
allelic exclusion. Finally, the cells proliferate and diﬀerentiate
into the DN4 stage. The overall process resulting in allelic
exclusion as well as cellular survival, proliferation, and dif-
ferentiation is referred to as β-selection and represents the
ﬁrst checkpoint in T-cell development [13]. This checkpoint
ensures that cells lacking productive TCRβ genes do not
proceed further in development. The cells that have not re-
ceived a pre-TCR signal die by apoptosis, unless they were
previouslypredisposedtodiﬀerentiateintotheγδ T-cellline-
age by the expression of TCRγ and TCRδ chains. Interest-
ingly, pre-TCR signaling has also been linked to the inhibi-
tion of the tumour suppressor gene, p53, which functions
in response to DNA damage [14]. An accumulation of p53
causes a cell-cycle arrest by activation of cell-cycle inhibitor
genes such as p21, to support DNA repair. Alternatively,
unrepaired DNA damage can also cause p53-induced death
by activation of proapoptotic molecules. The mechanisms
that link pre-TCR signaling to p53 induction have yet to be
established.
Following β-selection, CD8 is upregulated slightly earlier
than CD4 in mice, resulting in cells at the immature CD8
singlepositive(ISP)stage.ISPcellscanbedistinguishedfrom
the mature CD8+ single positive (SP) cells by lack of cell sur-
face TCRβ. As the cells progress into the CD4+CD8+ (double
positive, DP) stage, the expression of Rag genes is reinstated
and TCRα gene rearrangements take place. TCRα chains pair
up with the TCRβ chains and the CD3 components to form
the mature TCRαβ complex, which interacts with peptide-
MHC complexes expressed by the thymic stromal cells or
thymus-resident APCs. TCR interactions with MHC and
self-peptide result in positive and negative selection of DP
thymocytes, which represent a second checkpoint in T-cell
development and result in the generation of mature CD4+
and CD8+ SP cells.
3.CriticalRegulators of
EarlyT-CellDevelopment
Proper development of T cells depends on the timing and
level of transcription of lineage-speciﬁc regulatory genes.
Duringhematopoiesis,transcriptionfactorscoordinatecom-
plex developmental events by modulating an array of genes
that reduce multilineage potential and steer development
toward particular lineage fates [15]. The activity of the trans-
cription factors depends on their dosage, availability of their
partners, as well as their overall binding speciﬁcity and
aﬃnity for a consensus DNA sequence. Transcription factors
that are important for T-cell speciﬁcation and commitment
include Notch/CSL, GATA-3, TCF1, Bcl11b, and E proteins.
3.1. Notch Signaling. Notch signaling is an evolutionarily
conserved mechanism that inﬂuences cell fate through cell-
cell interactions. Notch proteins are transmembrane recep-
tors that signal in a ligand-dependent manner. Flies have
one Notch receptor, and two ligands: Serrate and Delta.
Mammals, however, possess four Notch receptors (Notch1 to
4) and ﬁve ligands: two Serrate-like ligands called Jagged-1
and Jagged-2, and three Delta-like (DL) ligands called DL1,
DL3, and DL4. Upon receptor-ligand engagement, a series
of proteolytic cleavages take place that liberate the intra-
cellular segment of Notch (ICN). ICN is the active form
of Notch, which binds to CSL (CBF-1/RBP-Jκ in mammals,
SuppressorofHairlessinDrosophila,Lag-1inC.elegans)dis-
placing the Groucho corepressor and recruiting coactivators
such as Mastermind to the complex. These events initiate
transcription of Notch-target genes, such as Hes1, Deltex1,
CD25, pTα,a n dTCRβ [16].
Among the four Notch receptors, Notch1 plays an indis-
pensable role in T-cell development, particularly in the T/B
lineage choice. Mice deﬁcient for Notch1 in HSCs display an
arrest at the DN1 stage of T-cell development and generate B
cells intrathymically (Figure 1(a))[ 17]. Furthermore, condi-
tionalinactivationofNotch1attheDNstageshasshownthat
Notch1 signaling is necessary for TCRβ rearrangement and
for generation ofαβ but not γδ T cellsfromDN3 progenitors
[18–20]. Although thymocytes also express Notch2 and
Notch3, mice deﬁcient for either of these receptors do
not have pronounced disturbances in T-cell development
[21–23]. Likewise, Notch4-deﬁcient mice do not have any
detectable defects in T-cell development [21]. Interestingly,Clinical and Developmental Immunology 3
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Figure 1: Key transcription factors in early T-cell development. Regulation of early T-cell development occurs through the coordinated
action of transcription factors. (a) GATA3 is important for the generation of DN1 cells, and GATA3−/− mice fail to produce any T-cells.
Inactivation of GATA3 during DN stages results in a block at the DN3 stage due to defects in TCRβ expression. When GATA is inactivated at
the later stages of T-cell development, no CD4 SP cells can be generated. Notch1 signalling is indispensable for T-cell speciﬁcation and
commitment since mice deﬁcient in Notch1 give rise to intrathymic B cells at the expense of T cells. Notch1 inactivation during DN stages
arrests T-cell development at the DN3 stage due to the defects in V-(D)J rearrangements of the TCRβ locus. Inactivation of TCF1 and LEF1
simultaneously results in the partial block at the DN3 stage and a complete block at the ISP stage as cells fail to rearrange TCRα locus. Lastly,
Bcl11b is essential for the speciﬁcation into the T-cell lineage. Bcl11b−/− cells fail to progress past the DN2 stage of T-cell development, and
instead,diﬀerentiateintoNKcells.(b)T-cellblocksassociatedwithmutationsinHEB,E2Aand/orE2-2E-proteinsandtheirantagonists,Id1
andId2.Solidbluntlinesindicatecompletedevelopmentalarrest,whiledottedbluntlinesindicateapartialdevelopmentalarrest.DN:double
negative, DP: double positive, SP: single positive, ISP: immature single positive, NK: natural killer, B: B lymphocytes.
progenitors constitutively expressing ICN develop into T
cellsinbone-marrowattheexpenseofBcells[24],indicating
that the bone marrow environment is well equipped to
support T cell development apart from the lack of DL Notch
ligands [25]. Although Notch1 receptor has the capacity to
interact with either DL1 or DL4 [26], DL4 represents the
primary physiological partner for Notch1 receptor in T-cell
development [27, 28]. Thymic stroma, therefore, provides
essential Notch ligands that are not expressed by the bone-
marrow stroma, which helps to explain the unique capacity
of the thymus to support T-cell development.
3.2. GATA3. The GATA family includes three zinc-ﬁnger
transcription factors, GATA1, GATA2, and GATA3, which
bind to the consensus GATA motif in DNA. Within the
hematopoietic system, all three GATA factors are expressed
in the hematopoietic progenitors; however, GATA1 is also
expressed in the cells of the myeloid origin, such as ery-
throcytes, mast cells, eosinophils, and megakaryocytes, while
the expression of GATA2 is limited to mast cells and
megakaryocytes [29]. GATA3, on the other hand, is most
abundantlyexpressedinTcellsandNKcells[30–32].During
T-cell development, the expression of GATA3 gradually in-
creasesfromtheDN1totheDN3stagethendiminishesatthe
DN4 stage. GATA3 is repressed at the DP stage and becomes
upregulated again in the CD4 SP cells, but it stays oﬀ in the
CD8 SP cells [33].
GATA3−/− mice die at E11 due to defects in the develop-
ment of the central nervous system [34]. The essential role
of GATA3 in the generation of T cells was revealed in
experiments involving antisense oligos against GATA3 [35],
and by generation and examination of blastocyst chimeras4 Clinical and Developmental Immunology
from GATA3−/− and Rag-2−/− embryonic stem cells (Fig-
ure 1(a))[ 36]. GATA3 is also necessary for the generation
of ETPs [32]. Conditional inactivation of GATA3 at the DN
stage of T-cell development has revealed that GATA3 is also
required for passage through β-selection and for the proper
expression of TCRβ protein [37]. Inactivation of GATA3
at the later stages of T-cell development has shown that
GATA3 is also essential for the generation of CD4+ SP cells
[37, 38]. GATA3 binds to the promoter regions and directly
regulates the expression of other genes important for T-cell
development, such as the Rag genes [39] and Th-POK, a
CD4 cell specifying transcription factor [40]. Elevated levels
of GATA3 in early T-cell development inhibit T-cell develop-
ment by downregulating genes involved in T-cell speciﬁca-
tion [41].
3.3. TCF1. Wnt genes encode numerous Wnt factors, which
are soluble glycoproteins secreted by thymic epithelial cells.
Wnt factors provide intracellular signaling to diﬀerent cell
types, including developing thymocytes. Wnt-mediated sig-
naling is initiated when Wnt binds to Frizzled receptors and
the low-density lipoprotein receptor-related protein (LRP)-5
and LRP6 on the cell surface of developing thymocytes [42].
Thesignalingcascadestabilizescytoplasmicβ-catenin,which
translocates into the nucleus and displaces a corepressor
called Groucho from the T-cell factor 1 (TCF1) and the lym-
phoid enhancer factor 1 (LEF1) transcription factors. Stabi-
lizedβ-catenincollaborateswithpre-TCRsignalingtoensure
thymocyte survival [43, 44]. In the absence of Wnt, β-cate-
nin is targeted for degradation by ubiquitination [45], thus
leaving the TCF1/Groucho complex to function as a trans-
criptional repressor.
TCF1 and LEF1 share a homology domain with proteins
of the high mobility group (HMG) family. The expression of
TCF1 is restricted to T cells, with the highest expression
occurring across the β-selection checkpoint and at the ISP
stage of T-cell development [46]. T-cell development is
impaired at multiple stages in TCF1-deﬁcient mice (Fig-
ure 1(a)). First, there is a complete block at the DN1 stage
when TCF1−/− stem cells are cultured on OP9-DL4 stroma,
which support T-cell development in vitro [47]. Second, in
TCF1−/− mice, there is a partial block at the DN1 to DN2
transition. Lastly, there is a marked accumulation of cells at
theISPstageandreducedoverallnumbersofthymocytes[46,
48, 49]. LEF1−/− mice have many abnormalities, but none
that are associated with thymopoiesis [50]. The potential
redundancy between the two factors was tested by generating
mice deﬁcient in both TCF1 and LEF1 [50]. Indeed, T-cell
development was partially blocked at the DN3 stage and
completely blocked at the ISP stage in TCF1/LEF1−/− mice
due to the impaired expression of the TCRα gene.
3.4. Bcl11b. Bcl11b (B-cell lymphoma/leukemia 11b) is a
tumour suppressor gene that encodes for three zinc-ﬁnger
transcriptionfactors:α,β,andγ.Bcl11bαandβareexpressed
at high levels in the thymus, while the expression of γ is
low [51]. The gene was discovered while studying the thymic
lymphomas in mice with mutations or deletions in the
Bcl11b gene locus [52]. A Bcl11b homologue exists called
Bcl11a, which functions as an oncogene in certain B-cell
leukemias that involve Ig heavy-chain gene translocations
[53].
An appreciation for the importance of Bcl11b in T-cell
development stemmed from studies involving Bcl11b knock-
outmice.Bcl11b−/− thymocyteshaveseveredefectsinV-(D)J
TCRβ gene rearrangements resulting in apoptosis and arrest
attheISPstage[51].Thetimingofdevelopmentalarrestsug-
gested that Bcl11b has a regulatory connection with TCF1,
and recent evidence suggests that Bcl11b is a direct target of
TCF1 [47]. Furthermore, conditional inactivation of Bcl11b
at earlier stages of T-cell development revealed a block at
the DN2 stage and an increased production of NK cells
[54, 55]. Bcl11b, like TCF1, is directly upregulated by DL-
Notch signaling, implicating it as a mediator of the impact
of Notch1 on alternative lineage choice. These studies have
identiﬁed Bcl11b as a critical factor for early T-cell develop-
ment (Figure 1(a)).
3.5. E Proteins. E proteins belong to the class I basic helix-
loop-helix (bHLH) family of transcription factors. They
control a variety of developmental processes in vertebrates
such as myogenesis, neurogenesis, pancreatic development,
and lymphopoiesis [56]. All E proteins possess a stretch of
basic amino acids capable of binding DNA. Furthermore, E
proteins function as homodimers as well as heterodimers
withotherEproteinsorHLHfactors.Thecrystalstructureof
the bHLH domain revealed that each subunit of the dimer
contacts one half of the E-box site [57]. The contact with
DNA is established via the basic region, while the HLH
domain participates in dimerization. Binding to DNA, how-
ever, is not suﬃcient to activate transcription; rather, E pro-
teins possess one or two activation domains (AD1 and AD2)
[58–60], which mediate transcription by recruiting coacti-
vators or corepressors to the complex. A repressive function
may be conferred on E proteins upon binding to ETO fac-
tors, whereas activation may be enhanced by recruiting p300
to the transcription complex [61]. These factors competi-
tively bind to the AD1 domain, enabling context-dependent
regulation of gene expression.
The E protein family is comprised of three members,
E2A, E2-2,a n dHEB; the timeline of their discovery is out-
lined in Figure 2. E proteins are indispensable for the gene-
rationofLMPPsandHSCs,andfornormalB-cell,T-cell,and
plasmacytoid DC (pDC) development. Each gene encodes
two proteins, as illustrated in Figure 3(a). The genes have
alternative names as follows: E2A (aka TCF3 or ALF2), E2-
2 (aka ITF2 or TCF4), HEB (aka TCF12, ALF1, or ME1).
The E2A gene locus gives rise to E47 and E12 by alternative
splicing[72].TheHEBgenelocusontheotherhand,hastwo
transcription start sites which are responsible for generating
the long form of HEB, called HEBCan, and the short form
of HEB, called HEBAlt [71]. The E2-2 gene locus has the
same type of genomic structure as the HEB gene locus, and
also produces two forms, E2-2Can and E2-2Alt. As shown in
Figure 3(b), the HEB gene locus is organized into 21 exons
and spans a genomic area that is over 200kb in size [71].Clinical and Developmental Immunology 5
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Figure 2: Timeline of E-protein discovery. In 1985, Ephrussi et al. identiﬁed regions in the immunoglobulin (Ig) heavy chain gene enhancer
(μE1–μE5)thatwereoccupiedbyunidentiﬁedDNA-bindingproteinsintheB-celllines,butnotinnonlymphoidcells[62].Theregionshada
CANNTGconsensussequence,whichwaslaternamedanE-box.In1989,Murreetal.discoveredthatE-boxesintheIg-heavyandlight-chain
enhancers were occupied by two novel proteins, which they named E47 and E12 [63]. These were the ﬁrst E-proteins discovered, so called
because they bind to the E-box sites. In 1990, the search for transcription factors that bind Ig light-chain enhancer sites (κE1–κE3) revealed
a second E-protein, ITF-2A [64], later named E2-2Alt [65]. Concurrent studies by Hu et al. involved the use of the μE2 sequence to screen a
cDNA library from HeLa cells, a human cell line, which led to the discovery of the third E-protein in 1992 [66]; the mouse counterpart was
discoveredlaterthatyear[67].ThisproteinwasnamedHEB(HeLaE-boxbindingfactor).In1997,asplicevariantofE2-2wasidentiﬁed[68]
and named ITF-2b (now called E2-2Can), which in contrast to E2-2Alt had an inhibitory eﬀect on the promoter of a muscle-speciﬁc gene
[69]. In 1999, Anderson et al. set out to identify transcription factors involved in T-cell speciﬁcation by screening a SCID (severe combined
immunodeﬁcient)-thymocytecDNAlibrary.ThesearchrevealedanovelHEBclone[70],whichwastranscribedfromtheHEBlocusfromits
own transcriptional start site located near a unique alternative (Alt) exon, homologous to E2-2Alt [71]. The presence of the Alt exon resulted
in naming this E-protein HEBAlt, and referring to the canonical HEB as HEBCan.
HEBCanisencodedbyexons2–20,andexcludestheAltexon
by alternative splicing. The transcription of HEBAlt initiates
just upstream of a unique Alt exon, and the transcript shares
exons 9–20 with HEBCan. An ankyrin-like exon can be in-
cluded in HEBCan but does not appear to be present in
transcripts cloned from thymocyte cDNA libraries [70, 71].
The Alt exon encodes for a 23 amino acid Alt domain, which
is 80% identical to the Alt domain of E2-2Alt. Amino acid
alignment of Alt domains from HEBAlt cDNA from ﬁsh,
chicken, mouse, and human revealed a high degree of iden-
tity, indicating that the Alt domain plays an important and
conserved function in vertebrates.
4.NegativeRegulationofEProteinFunction
E proteins are expressed widely in mouse tissues. Their func-
tions are negatively regulated by three mechanisms: through
direct competition for the E box DNA binding sites, by
posttranslational modiﬁcations, or through protein-protein
interactions. The transcription factor ZEB has been shown
to compete for the E-box binding sites within the Ig heavy-
chain gene enhancer, thus inhibiting E protein activity in
a cell-speciﬁc manner [73]. Posttranslational modiﬁcation,
such as ubiquitination of E2A proteins upon signaling
through Notch1 receptor [74] or calmodulin-mediated inac-
tivation of E2A [75], represents another potential mecha-
nism by which E protein function is regulated. In addition,
HEB-Tal1 heterodimers suppress expression of some HEB
target genes through competitive binding to the E box sites
[76]. Lastly, Id factors, which lack DNA-binding capacity,
antagonizeEproteinfunctionbyformingstableinactiveId/E
protein heterodimers [77]. This form of negative regulation
seems to be the most well-understood mechanism by which
E-protein function is regulated during T-cell development.
There are four mammalian Id factors, Id1, Id2, Id3, and
Id4 [78], which vary in tissue distribution. Id1 and Id3 fac-
tors are widespread in adult and embryonic mouse tissues
[65]. In contrast, Id2 transcripts are only detected in bone
marrow,testes,andbrainofadultmiceandinfetalliversafter
13.5 days of gestation [79]. Id4 is not expressed in the fetal
liver or any of the adult lymphoid tissues; its expression is
limited to kidney, testes, and brain [80]. The importance6 Clinical and Developmental Immunology
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Figure 3: Structure of E-proteins. (a) E-proteins belong to the basic helix-loop-helix (bHLH) family of transcription factors. There are three
genes, each encoding for two proteins: HEB (HEBCan and HEBAlt), E2-2 (E2-2Can and E2-2Alt), and E2A (E47 and E12). While E2A
proteins are produced by alternative splicing, HEB and E2-2 factors are generated by independent transcription start sites and alternative
splicing. All six transcription factors have a basic helix-loop-helix (bHLH) domain, which enables transcription factor dimerization and
binding to the DNA. Activation domains 1 (AD1) and AD2 help recruit coactivators to the transcriptional complex. The Alt domain replaces
AD1foundinthecanonicalformsofE-proteinsandisconservedbetweenmouseHEBAltandE2-2Altaswellasthroughvertebrateevolution.
(b) Organization of HEB gene. Vertical grey bars represent exons. Protein domains encoded by exons are shown as horizontal bars. Numbers
above exons represent exon numbers, while numbers between exons indicate genomic distance in kb. pDC: plasmacytoid dendritic cells,
LMPPs: lymphoid primed multipotent progenitors.
of Id factors in lymphoid development has been revealed
by gene knockout and transgenic studies. Studies involving
Id2−/− mice revealed that this factor is essential for the gene-
ration of NK cells [81]a n dD C s[ 82]. Transgenic expression
of Id1 under the control of the lck promoter led to a severe
block at the DN1 stage of T-cell development [83]. Lastly,
Id3 overexpression promoted NK cell development at the
expense of T cells [84]. Collectively, these studies have shown
that Id factor interference with E-protein activity leads to
severe perturbations during lymphoid development.
5.E2AandE2-2inHematopoiesis
The functions of E proteins have been most extensively
studied in the context of B lymphopoiesis. In B cells, E2A
proteins function as homodimers, stabilized by disulﬁde
bonds in a B-cell speciﬁc manner [85]. E2A−/− mice lack B
cells in fetal liver, bone marrow, and spleen and are prone to
die shortly after birth [86]. In the absence of E2A, the early
progenitors fail to activate early B-cell developmental genes,
such as early B-cell factor (EBF) and the paired box protein
5 (Pax-5), as well as the B-cell speciﬁc expression of Rag
genes [87–89]. As a result, E2A−/− cells fail to undergo Ig
gene rearrangements and are arrested at the earliest stage
of development [88]. In T-cell development, deletion of
E2A results in an early partial arrest at the DN1 stage,
inappropriate traversal through β-selection, and increased
positive selection of DP thymocytes (Figure 1(b))[ 90–92].
Since E proteins have been shown to compensate for each
other [93, 94], studies involving a simultaneous deletion
of E2A and HEB were done. These studies revealed defects
that were not observed upon deletion of either gene alone.
Deletion of E2A and HEB during DN stages revealed a role
for E proteins in suppressing proliferation prior to pre-TCR
signaling [95]. When both E proteins were deleted in later
stagesofT-celldevelopment, DPcellsdeveloped to theCD8+
lineage in the absence of TCR, indicating inappropriate
positive selection [96]. In addition, E2A also regulates the
expression of Rag g e n e si nC L P s[ 89]a n dL M P P s[ 97]. In
contrast to E2A, the function of E2-2 is not as well charac-
terized. The most prominent known function of E2-2 is in
the regulation of pDC development [98, 99]. In T-cell deve-
lopment,E2-2hasbeensuggestedtoplayaroleatβ-selection
since E2-2−/− mice display an accumulation of DN3 cells
(Figure 1(b))[ 100].
6. HEBinHematopoiesis
The importance of HEB factors in lymphopoiesis was revea-
led by studies involving HEB mutant mice. First, HEB−/−
mice were generated by deleting a segment of the bHLH
domain, thereby targeting both HEBCan and HEBAlt [93].
In contrast to E2A knockout mice, HEB−/− mice produce B
cells, although in reduced numbers [93]. When compared toClinical and Developmental Immunology 7
otherEproteins,lossofHEBhasthemostprofoundeﬀecton
T-celldevelopment(Figure1(b)).HEB−/− micehavereduced
thymic cellularity and display an accumulation of CD8+
ISP cells [101], reminiscent of the arrest seen in TCF1−/−
and Bcl11b−/− mice. Since the defects observed in HEB−/−
thymocytes could not be repaired with anti-CD3 treatment
or upon transgenic TCR expression, the functions of HEB
were proposed to be either parallel with or downstream of
pre-TCR signaling [101]. Moreover, mutant mice expressing
HEB without the basic region of the DNA-binding domain
render HEBCan and HEBAlt capable of dimerizing but
incapableofbindingDNA.Thisdominantnegativemutation
(HEBdn) resulted in a severe block at the DN3 stage of T-
cell development [102]. Since T-cell precursors failed to pro-
duce V-(D)J rearrangements, HEB was implicated in the reg-
ulation of TCRβ gene rearrangement. HEB is also involved in
the regulation of pTα [103]a n dCD4 [104] gene expression,
as well as the rearrangement of TCRα gene [105]. However,
the relative contributions of HEBAlt and HEBCan to these
processes are not well understood.
The arrest at the ISP stage of development in TCF1−/−,
Bcl11b−/−, and HEB−/− mice brings up the question of how
these genes are connected, and how they might impact the
expression of CD4. We have shown that IL7R signaling is
sustained in HEB−/− DN cells [106]. It is, therefore, possible
that HEB aids in the downregulation of IL7R signaling
after β-selection, which is necessary to prevent interfe-
rence with the upregulation of TCF1, LEF1, and RORγ genes
and transition past the ISP stage of development [107].
HEBCan plays an important role in initiation of CD4 gene
expression [104], raising the question of whether the CD8+
ISPcellsintheHEB−/− micerepresentedDPcellsindisguise.
However, the cycling proﬁle and intracellular TCRβ chain
expression of these cells suggested otherwise [101]. GATA3 is
essential for CD4 gene expression, whereas Runx3 is a direct
repressor of CD4 [108, 109]. We found that although HEB
deﬁciency at the DN3 stage did not aﬀect the expression
of GATA3, transgenic reconstitution of HEB−/− cells with
HEBAlt resulted in the upregulation of CD4 to generate DPs
[110]. Therefore, another possibility is that HEB factors, and
HEBAlt in particular, function in repressing Runx3 protein
expression or activity. This remains to be tested.
Our studies involving the retroviral overexpression of
eitherHEBCanorHEBAlthaveshedlightonthefunctionsof
individual HEB factors in lineage speciﬁcation and develop-
mental fate decisions. For instance, ectopic overexpression of
HEBAlt in LSK cells led to enhanced speciﬁcation into the T-
cell lineage [71] and a reduced capacity to generate myeloid
cells [111] in presence of DL1-Notch1 signaling. During B-
cell development, HEBAlt overexpression suppressed B-cell
potential, even in the absence of DL-Notch1 signals [111].
Lastly, HEBAlt was also shown to play a role in lympho-
myeloid speciﬁcation since precursors with a strong myeloid
potential adopted the T-cell fate upon overexpression of
HEBAlt [112]. However, the precise mechanisms by which
HEBAlt guides T-cell development and fate choice remain to
be determined.
In our recent studies, we have shown that HEB−/− mice
have an early block in T-cell development, which was allevi-
atedinpartupontheadditionofanHEBAlttransgenedriven
by the lck promoter. Furthermore, we identiﬁed pTα and
CD3 signaling components as speciﬁc targets of HEBAlt
during β-selection [110]. In addition, HEB−/− mice also had
a defect in T-cell commitment, with compromised Notch1
function and a tendency to become DN1-like cells [106].
The DN1-like cells could be induced to diﬀerentiate into
thymic NK cells, revealing a role for HEB in the T/NK cell
lineage decision. Importantly, a new set of interactions were
revealed among HEB, Notch1, and GATA3, which regulate
the T-cell fate choice in developing thymocytes. Conditional
inactivation of either HEBCan or HEBAlt alone will allow
for dissociation of their individual functions during T-cell
development.
7. HEBin the GeneRegulatory Network
C o ntr o llingth eEarlyT -C ellDev elo pm e nt
The gene networks that operate during early T-cell develo-
pment integrate developmental regulatory states with the
appropriate environmental signals to generate T cells. Al-
though many individual factors have been identiﬁed, the
connections that exist among them have not yet been well
established. Bcl11b, HEBAlt, and TCF1 are positively reg-
ulated by Notch signaling in thymic precursors, and both
Bcl11b and HEBAlt are sharply upregulated at the DN2a
stage of T-cell development, just prior to commitment [47,
54, 71]. Moreover, precursors from both Bcl11b−/− and
HEB−/− mice generate NK cells, suggesting that both of
these factors are needed to suppress the NK cell fate. Since
Bcl11b−/− thymocytes are arrested at the DN2 stage, whereas
HEB−/− cells are arrested later in development, it could be
proposed that HEBAlt expression is downstream of Bcl11b.
However, HEBAlt expression is not considerably reduced in
Bcl11b−/− precursors at early stages of development [54].
Likewise,Bcl11bisnotreducedinRag1−/−HEB−/− DN3cells
as compared with Rag1−/− DN3 cells (M. Braunstein and M.
K. Anderson, unpublished results). Moreover, constitutive
Notch signaling did not rescue T-cell development in the
absence of HEB [106], indicating that Notch target genes are
not suﬃcient to drive T-cell development in the absence of
HEB factors. We, therefore, propose that HEBAlt and Bcl11b
functioninparalleldownstreamofNotchsignalingtospecify
the T-cell fate, as illustrated in our gene regulatory network
model (Figure 4).
In early thymocytes, E2A is necessary for the initiation
of Notch1 expression, which in turn activates HEBAlt gene
expression. TCF1 is also required for the acquisition of the
T-cell identity [47].HEBAlt,therefore,mustcollaboratewith
TCF1 to enhance speciﬁcation to the T-cell lineage, whereas
Bcl11b promotes T-cell development indirectly by inhibiting
NK-celldevelopment.Indeed,HEBAltandTCF1regulatethe
expression of components of the pre-TCR signaling pathway
[47, 110], whereas none of the pre-TCR genes were shown to
be aﬀected by the loss of Bcl11b [54]. Together these studies
indicate that HEB factors are required for the integration of
pre-TCR and Notch signals at β-selection and suggest that
HEBAlt in particular plays a crucial role in this process.8 Clinical and Developmental Immunology
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Figure 4: Gene regulatory network model operating in early T-cell
development. E2A positively regulates Notch1 expression, which
induces the expression of HEBAlt, Bcl11b, and IL7R. HEBAlt
p o s i t i v e l yr e g u l a t e sT - c e l lg e n e s ,s u c ha sp T α a n dN o t c h 3 ,w h i c hi n
turn upregulates NF-κB signaling. Bcl11b negatively regulates Id2
and Gﬁ1b to balance the expression of GATA3, thus limiting the
NK-cell potential. HEBAlt may also regulate GATA3 indirectly
through Gﬁ1b. HEBAlt and Notch1 upregulate pTα and TCRβ,t h e
components of pre-TCR, thus promoting transition from the
DN2 to the DN3 stage of T-cell development. Pre-TCR signaling
upregulates Id3, which inhibits the activity of E2A and HEBAlt at
the β-selection checkpoint. The inhibition of HEBAlt activity past
the DN3 stage is important as it disrupts the positive feedback
loop between Notch3 and NF-κB ,w h i c hm a y ,o t h e r w i s e ,l e a dt o
leukemogenesis. Green arrows show positive inputs, red blunt
arrows show negative inputs. Established connections are shown by
solid arrows, and indirect or proposed connections are shown by
dashed arrows.
Although enforced Notch1 signaling was insuﬃcient to
support the DN to DP transition in HEB−/− precursors, it
was able to eﬀectively restore T-cell potential and suppress
NK cell potential in these precursors [106]. It is tempting to
speculate that under these conditions it was the induction
of Bcl11b by Notch1 signaling that inhibited NK cell devel-
opment. Bcl11b inhibits the expression of Id2 [54], allowing
E2A and HEB factors to maintain the expression of Notch1
and pre-TCR complex genes. GATA3 is negatively regulated
by Gﬁ1b [113].Therefore,theinductionofGﬁ1bbyE2Aand
HEB [114] coupled with the repression of Gﬁ1b by Bcl11b
[54] allows ﬁne tuning of the GATA3 levels needed for T-cell
development. Our recent results indicate that the transgenic
expression of HEBAlt is insuﬃcient to prevent transition
into the DN1-like state, consistent with an inability of
HEBAlt to upregulate Bcl11b and diversion to the NK cell
lineage (Figure 5). Taken together, these studies indicate
that HEBAlt and Bcl11b function in parallel during early T-
cell development and suggest that whereas Bcl11b inhibits
NK and stem-cell gene expression, HEBAlt collaborates with
T C F 1t oi n d u c eT - c e l lg e n ee x p r e s s i o n .
8. Life andDeath atthe β-SelectionCheckpoint
A lack of HEB gives cells a survival advantage in the absence
of DNA rearrangement [106]. Initiation of TCRβ rearrange-
ments is a key event orchestrating the normal outcomes of
β-selection. During rearrangement, double-stranded DNA
breaks are introduced which, if not repaired, result in death.
Thisremovescellsthatmayotherwisehaveoncogenicpoten-
tial.Forexample,cellsthataredeﬁcientfortheenzymeDNA-
dependent protein kinase (DNA-PK) are unable to resolve
D-J breaks, which leads to a developmental arrest at the
DN3 stage. As a consequence, the cells die via a p53-depen-
dent pathway. On the other hand, T-cell progenitors that
do not express Rag genes are unable to initiate DNA breaks
during D-J rearrangement. Indeed, these cells have very low
amountsofp53comparedtocellsthatareDNA-PKdeﬁcient,
indicating that they escape death initiated by the p53-
dependent pathway. However, Rag-deﬁcient T-cell precur-
sors still die. Although the mechanism of death has yet to
be determined, it is likely to involve a combination of events
that include upregulation of proapoptotic molecules, such
as Bim, by the FOXO factors and the absence of pro-sur-
vival signals that emanate from the pre-TCR, Notch1 and
IL7 signaling pathways [115]. Both pre-TCR and IL7R signal
via PI3K, which inhibits the activity of FOXO factors [116].
Bim is also upregulated directly by E2A [115]a n dc o u l db e
a direct target of HEB as well. In one scenario, accumulation
of E proteins in DN3 cells that lack TCRβ rearrangements
would result in upregulation of Bim and elimination by apo-
ptosis. Interestingly, Notch1 signaling also mediates survival
via Akt, not only in normal DN3 cells but also in Rag-def-
icient DN3 cells [117].
HEBCan and E2A factors suppress proliferation by up-
regulating cell-cycle inhibitors [118], which normally keep
DN3 cells without rearrangements in check. Interestingly, an
alternative outcome was available to certain HEB−/− DN3
cells at the time of β-selection: development into the thymic
NK cell lineage. Although HEB−/− T-cell precursors with
rearranged TCRβ genes and intact Notch1 signaling had the
ability to turn into DN1-like cells, the majority of the cells
that became DN1-like lacked TCRβ rearrangements and had
downregulated Notch signaling. Even though restoring full
Notch signaling did not restore the ability to pass through
β-selection in the absence of the pre-TCR, it did restore the
natural outcome of DN3 cells without rearrangements:
death. The mechanism by which Notch signaling could over-
come HEB deﬁciency to induce death is unknown. The
tumour-suppressive function of E2A [119] and likely HEB-
Can is in contrast with the activity of HEBAlt, as we have
observed that HEBAlt transgenic mice develop lymphoma,
possibly through sustained Notch1 signaling (M. Braunstein
and M. K. Anderson, unpublished results). Under normal
circumstances, both HEBAlt and Notch1 are downregulated
at β-selection. In the transgenic mice, however, Id3 was likely
insuﬃcienttoblocktheactivityofHEBAlt,whichmighthave
led to lymphomagenesis by maintaining Notch1 signaling
across the β-selection checkpoint.Clinical and Developmental Immunology 9
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Figure 5:DevelopmentalphenotypeofHEB−/−Rag-1−/− T-cellprogenitorsexpressingtransgenicHEBAlt.HEB+/− micewerebredwithRag-
1−/− mice to generate HEB+/−Rag-1−/− mice, which were timed mated to generate (a) HEB+/+Rag-1−/− and (b) HEB−/−Rag-1−/− embryos.
Similarly, HEB+/−Rag-1−/− mice were bred with HEBAltTg mice to generate HEBAltTgHEB+/−Rag-1−/− mice, which were timed mated to
generate (c) HEBAltTgHEB+/+Rag-1−/− and (d) HEBAltTgHEB−/−Rag-1−/− embryos. Fetal livers were genotyped, lineage depleted (lineage
positive fraction: B cells, myeloid cells, red blood cells). Fetal liver LSK (lineage negative, Sca1+,c k i t +) cells were sorted and cultured on OP9-
DL1 for 7 days to allow developmental progression to the DN3 stage. At day 7, lymphocytes were gated on the CD45+CD4−CD8− fraction
a n ds o r t e df o rt h eD N 3c e l l s( C D 4 4 −CD25+), which were cultured on fresh OP9-DL1 stroma with 5ng/mL IL7 and Flt3L. Four days later,
whole cell cultures were analysed by ﬂow cytometry. All plots were gated on the CD45+CD4−CD8− fraction.
9. Development of T versustNK Cellsin
the Thymus
From an evolutionary standpoint, Notch signaling is an
ancient pathway, whereas pre-TCR signaling is a relatively
new acquisition. The NK cell gene program, therefore, may
represent a default route for early progenitors in the ancient
thymus, which later in evolution became circumvented to
generate cells with rearranged receptors. Indeed, NK cells are
generated ﬁrst in the fetal thymus prior to any αβ Tc e l l s
[120]. Moreover, the requirements for GATA3 and IL7R are
common between T cells and thymic NK cells, and while the
development of thymic NK cells may not depend on Notch1
signaling [121], evidence for a role of Notch in thymic NK
cell development does exist [122]. Therefore, the evolution-
ary divergence of the thymic NK and T-cell lineages may be
mirrored by the developmental steps that give rise to each
lineage. HEB may in part be responsible for the separation of
these lineages, by modulating Notch signaling and selective
survival of β-selected T-cell progenitors, and by regulating
the levels of GATA3.
In our studies, thymic NK cells were derived from
HEB−/− DN3cellsthatwouldnothavesurvivedordeveloped
in the absence of Notch signaling, suggesting an initial role
for Notch in specifying a common T/NK progenitor. It is
alsopossiblethattNKcellsnormallyarisefromnoncanonical10 Clinical and Developmental Immunology
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Figure 6: Development of T versus tNK cells in the thymus. DN1 cells enter thymus at the corticomedullary junction (CMJ).This area is low
in DL4 but high in DL1 ligand; in addition, there is a low amount of IL-7 and SCF dispersed throughout a thymus. DN1c and DN1d cells
may be progenitors to a small number of B cells generated intrathymically. DN1a and DN1b cells represent canonical early T-cell progenitors
(ETPs), which migrate to the inner cortex, the area of high DL4 ligand concentration. In response to Notch signalling, ETPs turn on many of
the T-lineage speciﬁc genes and develop into DN2 cells. At the DN3 stage, the cells rearrange TCRβ genes and undergo β-selection, thus
expanding and taking up most of the space in the outer cortex. This is disadvantageous for those DN3 cells that have not rearranged TCRβ,
which may give rise to the thymic NK cells. Thus, a small percentage of NK cells may be generated in a thymus, mostly from the DN1e
progenitors, which are likely to remain near the CMJ region where the DL4 ligands are low and the IL-7 concentration is suﬃcient for the
thymic NK cell development.
precursors such as DN1c, DN1d, or DN1e cells. DN1e cells
are of particular interest because they already express high
levels of IL7R and Id2 [4, 6]. Although they do not have
strong proliferative potential, they do generate both T and
NK cells [4]. Interestingly, culturing DN1e cells on OP9
stroma that lacks DL expression yielded only 3% NK cells,
whereas culturing ETPs on OP9 stroma generated approx-
imately 40% NK cells. This raises the intriguing possibility
that DN1e cells are primed to become thymic NK cells but
need intermittent and/or low DL-Notch signals to give rise
to thymic NK cells (Figure 6). Consistent and/or high DL-
Notch1 signaling, on the other hand, would be expected to
promote noncanonical T-cell development from DN1e cells.
The DN1 and DN2 stages of T-cell development express
many progenitor-like genes [123, 124] that allows for their
experimental reprogramming into mast cells and NK cells.
Under normal conditions, however, the DN3 stage marks
the point of no return; at this stage, the cells either commit
to the T-lineage or die. The question then arises: what
deﬁnestheDN3stageandT-cellcommitment?Development
to the DN3 stage does not require the rearrangement of
TCRβ genes or the expression of Rag genes, as indicated by
the ability Rag-1−/− thymocytes to acquire the T-lineage
phenotypeuptothisstage.Instead,theupregulationofmany
other T-cell speciﬁcation genes must be used as the criteria
to determine the developmental status of an early T-cell pro-
genitor. Commitment, on the other hand, is deﬁned as the
inability to adopt alternative lineage choices. HEB−/− DN3
cells display an interesting and aberrant gene expression pat-
tern that speaks to these criteria: they have a partially acti-
vated T-cell program, and they maintain a limited ability to
diﬀerentiate into an alternative fate. Therefore, it is unlikely
that the HEB-deﬁcient DN3 cells, which can give rise to
thymic NK cells, reﬂect DN2 cells in disguise. Rather, the
transitionfromtheDN3toDN1-likestateinvolvesatrueloss
of T-cell identity in the absence of cell death.Clinical and Developmental Immunology 11
T h et h y m u sp r o v i d e sah i g h l ys t r u c t u r e da n do r d e r e d
environment, where Notch ligands and cytokines become
available in varying doses and in speciﬁc niches, tightly con-
trolling cellular development [125]. These restrictions pro-
moteearlyT-celldevelopmentandlimittheselectionofboth
DN3 cells that lack TCRβ rearrangements and thymic NK
cell development. A T-cell progenitor entering the thymus
through the CMJ is exposed to the DL1 ligand and SCF, but
low IL-7 availability (Figure 6). At this point, progenitors
such as DN1e cells, which are c-kit− and IL7R+,c o u l dp o t e n -
tially respond to DL1 but would be limited in their survival
and thus fail to generate abundant thymic NK cells. The dis-
tribution and levels of IL15 within the thymus still need to
be determined; however, it is likely that IL15 is only scarcely
available throughout the thymus given the small number of
thymic NK cells that are generated even in a Rag-deﬁcient
thymus. Lastly, the expression of chemokine receptors on
DN1e cells suggests that these cells may migrate towards
the medulla rather than the cortex, which could provide an
alternative set of signals that would promote NK cell deve-
lopment [6]. ETPs, on the other hand, lack IL7R but express
c-kit and chemokine receptors that would help with tran-
sition from the CMJ to the cortical region. In the cortex,
the rapid expansion of β-selected cells allows the T-cell pre-
cursors to outcompete and thus limit the survival and devel-
opmental capacity of DN3 cells lacking TCRβ rearrange-
ments. Thymic epithelial cells express abundant levels of IL7
throughout the entire fetal thymus from day E12.5 to E13.5
[126]. Therefore, the availability of IL7 within an E12.5–
E13.5 fetal thymus would be expected to encourage thymic
NK cell development. Indeed, thymic NK cells develop in
the fetal thymus before any DP cells are generated. After
E15.5,however,thethymussizeincreasesduetoproliferating
thymocytes and the proportion of epithelial cells producing
IL7 is correspondingly reduced. Approximately 15% of the
cells in fetal thymic organ culture are thymic NK cells,
whereas adult Rag-deﬁcient thymus contains approximately
4% thymic NK cells. By contrast, thymic NK cells represent
only 0.013% of the adult thymocyte population. Our results
showed that, although HEB−/− precursors had downregu-
lated Notch signaling and indeed gained DL independence,
they were nonetheless still dependent on IL7 to survive
[106].
10. Summary
In summary, HEB factors are essential mediators of T-cell
lineagespeciﬁcationandcommitment.HEBAltandHEBCan
play distinct roles in these processes, with HEBAlt inducing
T-lineage genes and suppressing myelopoiesis within the
thymus, whereas HEBCan appears to be more involved in
repressing the NK cell fate. These factors interface with
Notch1, TCF1, GATA3, Bcl11b, and Gﬁ1b to form a network
of interactions that not only initiates the T-cell program
but also incorporates positive feedback loops that sustain
it. Further study will be needed to address the question of
how HEBAlt and HEBCan function as homodimers, het-
erodimers with each other, or heterodimers with E2A, but
our work has clearly shown that both HEBCan and HEBAlt
are central factors in the early stages of T-cell development.
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